Pleasanton, California - Boster Bio Technology unlocks insights into cancer and neurological disorders with high-quality ...

Many biologics, such as monoclonal antibodies, are recombinant protein therapies. Diverse ultra-long CDRs can be swapped on the same antibody scaffold with minimal impact on scaffold structure and ...

Addgene is thrilled to have the expertise of this group of leaders in life sciences and technology as part of our management team and Board of Directors – a testament to the value of our vision for a ...

Recombinant proteins are important components for a wide range of applications, from therapeutic antibodies and vaccines to diagnostics and enzymes. Microbiosci is committed to advancing the science ...

Biocon Biologics Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved JOBEVNE™ (bevacizumab-nwgd), a ...

Gut Microbiota in Immuno-Oncology: A Practical Guide for Medical Oncologists With a Focus on Antibiotics Stewardship Bispecific antibodies (bsAbs) have emerged as a novel class of therapeutics, ...

Biocon's share price rose 5.5% after USFDA approved JOBEVNE, a biosimilar cancer drug. This marks the company's seventh USFDA-approved biosimilar and enhances its oncology portfolio, increasing ...

Jobevne is a recombinant humanised monoclonal antibody that is used to treat several types of cancer. It is a biosimilar to the reference product Avastine (bevacizumab), Biocon said. Jobevne is a ...

JOBEVNE, a recombinant humanized monoclonal antibody used to treat several different types of cancer, is a biosimilar to the reference product Avastin (bevacizumab). JOBEVNE is a vascular ...

YONGIN, South Korea, April 9, 2025 /PRNewswire/ -- GC Biopharma announced 09. Apr. 2025 that the Korean Ministry of Food and Drug Safety (MFDS) has approved its anthrax vaccine, BARYTHRAX, jointly ...